clinical trial · NCT06183086
PMCF Study on the Safety of Linovera® for the Treatment of Category-I Pressure Ulcers/Injuries
Pressure UlcerLinovera®
brief summary
To assess the safety and performance of Linovera® in the treatment of Category- I pressure ulcers/injuries.
started
Nov 14, 2023
primary completion
Nov 1, 2024
completion
Dec 1, 2024
last updated
Dec 27, 2023
detailed description
The aim of this clinical study is to generate further clinical evidence for the use and benefit of Linovera® in the treatment of Category-I PUs. The results of this study will generate further clinical evidence for the use and the benefit of Linovera® in this indication.
Furthermore, the proactive collection of clinical data for Linovera® will support the maintenance of this skin oil on the market, so that in the future other patients can receive the product for the treatment of Category-I PUs.
official title
Prospective, Multicentre, Single-arm, Controlled Study on the Safety of Linovera® for the Treatment of Category-I Pressure Ulcers/Injuries
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol